Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: A systematic review and meta-analysis

Critical Care

Volumn 16, Issue 6, 2012, Pages

  Wu, Youping ^a   Wang, Fei ^a   Fan, Xiaohua ^a   Bao, Rui ^a   Bo, Lulong ^a   Li, Jinbao ^a   Deng, Xiaoming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; BIOLOGICAL MARKER; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, HUMAN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTINGENCY TABLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; RECEIVER OPERATING CHARACTERISTIC; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMATIC REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADULT; BLOOD; REPRODUCIBILITY;

ADULT; BIOLOGICAL MARKERS; HUMANS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84870056881     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11884     Document Type: Article

References (51)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
2. Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997, 336:952-953. 10.1056/NEJM199703273361311, 9070479.
3. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474. 10.1378/chest.115.2.462, 10027448.
4. Pittet D, Rangel-Frausto S, Li N, Tarara D, Costigan M, Rempe L, Jebson P, Wenzel RP. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995, 21:302-309. 10.1007/BF01705408, 7650252.
5. Otero RM, Nguyen HB, Huang DT, Gaieski DF, Goyal M, Gunnerson KJ, Trzeciak S, Sherwin R, Holthaus CV, Osborn T, Rivers EP. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006, 130:1579-1595. 10.1378/chest.130.5.1579, 17099041.
6. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123. 10.1001/jama.1995.03520260039030, 7799491.
7. Adib-Conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 2007, 581:3723-3733. 10.1016/j.febslet.2007.03.074, 17428476.
8. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164:4991-4995.
9. Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141:9-15.
10. Kim J-H, Park E-Y, Kim W-H, Park W, Jeong H-C, Lee J-H, Kim E-K. Soluble triggering receptor expressed on myeloid cells-1: role in the diagnosis of pleural effusions. Tuberc Respir Dis 2007, 62:290-298.
11. Gibot S, Cravoisy A, Levy B, Béné MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350:451-458. 10.1056/NEJMoa031544, 14749453.
12. Su LX, Feng L, Zhang J, Xiao YJ, Jia YH, Yan P, Feng D, Xie LX. Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study. Crit Care 2011, 15:R250. 10.1186/cc10508, 3334801, 22023777.
13. Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med 2006, 32:1243-1247. 10.1007/s00134-006-0240-4, 16786330.
14. Jiyong J, Tiancha H, Wei C, Huahao S. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med 2009, 35:587-595. 10.1007/s00134-008-1333-z, 18936908.
15. Summah H, Tao LL, Zhu YG, Jiang HN, Qu JM. Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis. BMC Infect Dis 2011, 11:280. 10.1186/1471-2334-11-280, 3209451, 22014385.
16. Soud DEM, Amin OAI, Amin AAI. New era "soluble triggering receptor expressed on myeloid cells-I" as a marker for early detection of infection in trauma patients. Egypt J Anaesthesia 2011, 27:267-272.
17. Gamez-Diaz LY, Enriquez LE, Matute JD, Velasquez S, Gomez ID, Toro F, Ospina S, Bedoya V, Arango CM, Valencia ML, De La Rosa G, Gomez CI, Garcia A, Patino PJ, Jaimes FA. Diagnostic accuracy of HMGB-1, sTREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. Acad Emerg Med 2011, 18:807-815. 10.1111/j.1553-2712.2011.01113.x, 21762470.
18. Latour-Perez J, Alcala-Lopez A, Garcia-Garcia MA, Sanchez-Hernandez JF, Abad-Terrado C, Viedma-Contreras JA, Masia M, Gonzalez-Tejera M, Arizo-Leon D, Porcar MJ, Bonilla-Rovira F, Gutierrez F. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clin Biochem 2010, 43:720-724. 10.1016/j.clinbiochem.2010.03.001, 20303344.
19. Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care 2010, 25:362 e361-366.
20. Rivera-Chavez FA, Minei JP. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect 2009, 10:435-439.
21. Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, Kotzampassi K. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. J Trauma 2008, 65:1385-1390. 10.1097/TA.0b013e31814699cc, 19077631.
22. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007, 11:R38. 10.1186/cc5723, 2206456, 17362525.
23. Su L, Han B, Liu C, Liang L, Jiang Z, Deng J, Yan P, Jia Y, Feng D, Xie L. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 2012, 12:157. 10.1186/1471-2334-12-157, 3426475, 22809118.
24. Li L, Zhu Z, Chen J, Ouyang B, Chen M, Guan X. Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically ill, postoperative patients with suspected sepsis. Am J Med Sci 2012,
25. Gibot S, Béné MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho Bittencourt M, Quenot JP, Bollaert PE, Faure G, Charles PE. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012, 186:65-71. 10.1164/rccm.201201-0037OC, 22538802.
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012. 10.1001/jama.283.15.2008, 10789670.
27. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174. 10.2307/2529310, 843571.
28. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
29. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. 10.1186/1471-2288-3-25, 305345, 14606960.
30. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ 2002, 324:539-541. 10.1136/bmj.324.7336.539, 1122451, 11872558.
31. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005, 58:982-990. 10.1016/j.jclinepi.2005.02.022, 16168343.
32. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12:1293-1316. 10.1002/sim.4780121403, 8210827.
33. Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011, 11:41. 10.1186/1471-2288-11-41, 3102034, 21473747.
34. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 1.0 2010, Oxford, UK: The Cochrane Collaboration, Deeks JJ, Bossuyt PM, Gatsonis C.
35. Dinnes J, Deeks J, Kirby J, Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 2005, 9:1-113. iii.
36. Rucker G, Carpenter JR, Schwarzer G. Detecting and adjusting for small-study effects in meta-analysis. Biom J 2011, 53:351-368. 10.1002/bimj.201000151, 21374698.
37. Li J, Birkenheuer AJ, Marr HS, Levy MG, Yoder JA, Nordone SK. Expression and function of triggering receptor expressed on myeloid cells-1 (TREM-1) on canine neutrophils. Dev Comp Immunol 2011, 35:872-880. 10.1016/j.dci.2011.03.021, 21549750.
38. Bopp C, Hofer S, Bouchon A, Zimmermann JB, Martin E, Weigand MA. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol 2009, 26:504-507. 10.1097/EJA.0b013e328329afca, 19307971.
39. Hong-xia W, Chen B. Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis. World J Emerg Med 2011, 2:190-194.
40. How CK, Chern CH, Wu MF, Wang LM, Huang CI, Lee CH, Hsieh SL. Expression of the triggering receptor expressed on myeloid cells-1 mRNA in a heterogeneous infected population. Int J Clin Pract 2009, 63:126-133. 10.1111/j.1742-1241.2006.01193.x, 17343659.
41. Gibot S, Cravoisy A, Dupays R, Barraud D, Nace L, Levy B, Bollaert PE. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 2007, 39:604-608. 10.1080/00365540701199832, 17577825.
42. Sarafidis K, Soubasi-Griva V, Piretzi K, Thomaidou A, Agakidou E, Taparkou A, Diamanti E, Drossou-Agakidou V. Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates. Intensive Care Med 2010, 36:864-868. 10.1007/s00134-010-1819-3, 20232048.
43. Carlet J. Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am 1999, 13:483-494. xi, 10.1016/S0891-5520(05)70087-8, 10340179.
44. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 2005, 351:17-29. 10.1016/j.cccn.2004.08.018, 15563869.
45. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011, 66(Suppl 2):ii33-40.
46. Colonna M, Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 2003, 187(Suppl 2):S397-401.
47. Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett 2008, 116:111-116. 10.1016/j.imlet.2007.11.021, 18192027.
48. Cavaillon JM. Monocyte TREM-1 membrane expression in non-infectious inflammation. Crit Care 2009, 13:152. 10.1186/cc7882, 2717434, 19519945.
49. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, Figueroa-Figueroa S, Duarte-Rojo A, Guzman-Valdivia-Gomez G, Rodea-Rosas H, Torres-Gonzalez R, Sanchez-Fernandez P, Arriaga-Pizano L, Lopez-Macias C, Robles-Diaz G, Isibasi A. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 2009, 13:R69. 10.1186/cc7876, 2717428, 19442309.
50. Bingold TM, Pullmann B, Sartorius S, Geiger EV, Marzi I, Zacharowski K, Wissing H, Scheller B. Soluble triggering receptor on myeloid cells-1 (sTREM-1) is expressed in the course of non-infectious inflammation after traumatic lung contusion: a prospective cohort study. Crit Care 2011, R115.
51. Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 2002, 31:88-95. 10.1093/ije/31.1.88, 11914301.